ERBB2 and neoplasm: Among non‐TNBC patients, vertical orientation was predictive for better RFS (5 year RFS 96.0% vs 92.9%, P = .035) which was related to smaller tumor size, human epidermal growth factor receptor 2 non‐amplification, and lower Ki‐67 expression (All P < .01).